XML 40 R30.htm IDEA: XBRL DOCUMENT v3.19.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2019
STOCK-BASED COMPENSATION  
Schedule of ESPP expense incurred under the 2016 Employee Stock Purchase Plan and stock-based compensation expense incurred under the 2008 Plan

 

The following table summarizes ESPP expense incurred under the 2016 Employee Stock Purchase Plan and included in our accompanying unaudited interim condensed consolidated statements of operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 

 

Six Months Ended June 30, 

(in thousands)

    

2019

    

2018

    

2019

    

2018

Cost of sales

 

$

 3

 

$

 2

 

$

 6

 

$

 4

Research and development

 

 

 4

 

 

 2

 

 

 9

 

 

 3

Selling, general, and adminstrative

 

 

23

 

 

14

 

 

45

 

 

28

 

 

$

30

 

$

18

 

$

60

 

$

35

 

The following table susmmarizes stock-based compensation expense incurred under the 2008 Plan and included in our accompanying unaudited interim condensed consolidated statements of operations: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 

 

Six Months Ended June 30, 

(in thousands)

    

2019

    

2018

 

2019

    

2018

Cost of sales

 

$

28

 

$

24

 

$

49

 

$

42

Research and development

 

 

219

 

 

220

 

 

332

 

 

380

Selling, general, and adminstrative

 

 

2,316

 

 

1,520

 

 

3,862

 

 

2,702

 

 

$

2,563

 

$

1,764

 

$

4,243

 

$

3,124

 

Summary of Stock option and restricted stock activity

A summary of stock option and restricted stock activity under the 2008 Plan during the six months ended June 30, 2019 and 2018 is presented below:

 

 

 

 

 

 

(in thousands)

    

Options

    

RSAs

 

Outstanding December 31, 2017

 

767

 

86

 

Granted

 

151

 

65

 

Options Exercised/RSAs Vested

 

(111)

 

(33)

(1)

Forfeited

 

(16)

 

 —

 

Outstanding June 30, 2018

 

1,582

 

236

 

 

 

 

 

 

 

Outstanding December 31, 2018

 

759

 

117

 

Granted

 

160

 

122

(2)

Options Exercised/RSAs Vested

 

(114)

 

(42)

 

Forfeited

 

(18)

 

(2)

 

Expired

 

(1)

 

 —

 

Outstanding June 30, 2019

 

786

 

195